2021
DOI: 10.1093/jnen/nlab032
|View full text |Cite
|
Sign up to set email alerts
|

Asymmetry of Hippocampal Tau Pathology in Primary Age-Related Tauopathy and Alzheimer Disease

Abstract: Primary age-related tauopathy (PART) is a neurodegenerative entity defined as neurofibrillary degeneration generally restricted to the medial temporal region (Braak stage I–IV) with complete or near absence of diffuse and neuritic plaques. Symptoms range in severity but are generally milder and later in onset than in Alzheimer disease (AD). Recently, an early predilection for neurofibrillary degeneration in the hippocampal CA2 subregion has been demonstrated in PART, whereas AD neuropathologic change (ADNC) ty… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
35
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 21 publications
(38 citation statements)
references
References 52 publications
3
35
0
Order By: Relevance
“…To compare the Aperio ImageScope‐generated quantitative measurements against previously established semiquantitative measurements, we established a direct correlation between Thal phase and overall Aβ burden PPP (r = 0.69; P < 0.0001; Figure S3A in supporting information), Braak stage and overall p‐tau burden PPP (r = 0.57; P < 0.0001; Figure S3B), and CA2/CA1 p‐tau ratio (determined by previous semiquantitative scoring systems 7,21 ) and quantitative CA2/CA1 p‐tau ratio (r = 0.64; P < 0.0001; Figure S3C), confirming the validity of both techniques. These data also suggest, however, that there is a great deal of variation in hippocampal Aβ burden in Thal phase 2 and p‐tau burden in Braak stages III and IV, suggesting that the quantitative measures may be better at capturing the full extent of hippocampal pathology than more topographical measurements such as Thal phase and Braak stage (Figure S3A‐B).…”
Section: Resultsmentioning
confidence: 99%
“…To compare the Aperio ImageScope‐generated quantitative measurements against previously established semiquantitative measurements, we established a direct correlation between Thal phase and overall Aβ burden PPP (r = 0.69; P < 0.0001; Figure S3A in supporting information), Braak stage and overall p‐tau burden PPP (r = 0.57; P < 0.0001; Figure S3B), and CA2/CA1 p‐tau ratio (determined by previous semiquantitative scoring systems 7,21 ) and quantitative CA2/CA1 p‐tau ratio (r = 0.64; P < 0.0001; Figure S3C), confirming the validity of both techniques. These data also suggest, however, that there is a great deal of variation in hippocampal Aβ burden in Thal phase 2 and p‐tau burden in Braak stages III and IV, suggesting that the quantitative measures may be better at capturing the full extent of hippocampal pathology than more topographical measurements such as Thal phase and Braak stage (Figure S3A‐B).…”
Section: Resultsmentioning
confidence: 99%
“…11,26 The severity of cognitive impairment often observed in individuals with PART is surprising given the low level and localized nature of the tangle pathology, even considering greater than expected hippocampal CA2 region involvement 27 or medial temporal left-right asymmetry. 28 We therefore hypothesized that other age-related copathologies such as LATE-NC or vascular pathology may play a significant role in the cognitive decline of these patients. We also hypothesized that, in the presence of low levels of tau pathology, amyloid may contribute to cognitive decline independently of other copathologies.…”
mentioning
confidence: 99%
“…Neurofibrillary degeneration with a predilection for the hippocampal CA2 subregion, a feature of primary age-related tauopathy (PART), was not clearly observed. 20 In addition, AGs and extracellular ghost tangles, which are a characteristic feature in age-related NFTs, were mild. 11,[21][22][23][24] The mildness of tau pathological changes in neurons, in other words the resistance of neurons to tau pathologies, may be a factor in her exceptional longevity.…”
Section: Discussionmentioning
confidence: 99%